Biotech & MedTech

Coeptis Therapeutics’ Dave Mehalick on Making Cell Therapy Universally Accessible

April 30, 2024 — In a recent interview with InvestorNews, Dave Mehalick, Chairman, President, and CEO of Coeptis…